TCL Archive In Brief: NCAB To Ponder Organ Systems Program Fate, Cancer Centers Issues, Hear Surveillance Review January 29, 1988
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive In Brief: Kovac, Bunn Lead AACI; Hollings Researcher Wins Immunology Award; Turrisi Moves To SC September 16, 1994